Clinical pharmacokinetics of simotinib, an oral EGFR tyrosine kinase inhibitor,in patients with advanced NSCLC patients. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results